AssayCheX Process Control Panel for Luminex/Bio-Plex Immunoassays
So how good are your results? (An introduction to quantitative QC) Graham Jones Chemical Pathology St Vincents Hospital, Sydney.
( ( Clare Bruggeman.
The COULTER PRINCIPLE- Gold Standard in Cell Count and Cell Size
Aug2013 tumor normal whole genome sequencing
Is Brugia malayi’s cofactor-independent phosphoglycerate mutase (iPGM) druggable?
DCN Diagnostics. Design and Development of Lateral Flow Assay Systems
Thoughts on Biomarker Discovery and Validation Karla Ballman, Ph.D. Division of Biostatistics October 29, 2007.
Tox21: Transforming Environmental Health Protection Raymond Tice, Ph.D. Chief, Biomolecular Screening Branch ([email protected]) LINCS Consortium Kick-Off.
Metaplastic cancers of the breast (MCBs) are a distinct subgroup of breast cancers. These are a heterogeneous group of tumours with mixed epithelial and.
1 Application of DOE Methodology to SNP Assay Development Geetha Rajavelu Gretchen Kiser 2002 Quality & Productivity Research Conference Tempe, AZ June.